当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Masahide Higaki, Kentaro Shimokado
Background: Psychiatric problems of patients with head and neck cancers usually result from disfiguring, illness and treatment, adjustment to alterations of speech, eating and other functions including sexual activity. Alteration of body image, speech and eating are often seen. Psychiatry comorbidities are generally common findings in head and neck cancer patients. The major associated psychiatric disorders in them are anxiety and depression.
Materials and Methods: Reports of four of our patients diagnosed of Head and Neck Malignancies who developed psychiatric symptoms in the course of treatment are presented. The medical records of the patients were retrieved, information sought included biodata, clinical and histological information as well as treatment progression.
Results: A 55yrs old male with transglottic malignant laryngeal tumour developed severe depression in the course of treatment. A second 45yr old male diagnosed of a malignant sinonasal tumour developed Chemotherapy induced psychosis to rule out a frontal lobe syndrome. The third 44yr old female with malignant sinonasal tumour developed low mood while on treatment but did not meet the criteria for a psychiatric illness. The 4th, a 76yrs old male diagnosed of a malignant laryngeal tumour became delirious following diagnosis and did not take up the treatment offered.
Conclusion: The tendency for patients with head and neck tumors to develop psychiatric disorders in the course of management is high on account of visible changes in body structures and limitations of functions.
Recommendations: There is the need for a multidisciplinary approach and the relevance of psychiatrists and psychologists in pretreatment evaluation as well as in the course of treatment.